袖状胃切除与胃旁路术后4年急性医疗利用与费用的全国性索赔研究
基于美国全国保险索赔数据库,匹配年龄、性别、日历时间、糖尿病及基线急性医疗使用后,比较4263例袖状胃切除(SG)与4520例Roux-en-Y胃旁路(RYGB)患者术后4年内的急诊和住院利用及费用。结果显示SG患者急诊就诊和住院风险略低,尤其消化系统相关事件,早期高费用几率更低,但费用差异至第3、4年减弱。
要点
- SG患者术后4年急诊就诊风险略低于RYGB(aHR 0.90),住院风险更低(aHR 0.80)。
- 消化系统相关事件的急诊和住院风险在SG组显著更低(aHR分别为0.68和0.61)。
- SG早期高急诊费用和高总急性费用的几率更低,但第3、4年费用差异不再显著。
核心结论
- SG可能与较少的需急诊和住院的并发症相关,尤其是消化系统疾病。
- SG的急性医疗费用优势可能随时间减弱。
研究设计与样本
- 全国保险索赔数据库识别2008至2016年接受SG或RYGB的成人。
- 按年龄、性别、日历时间、糖尿病和基线急性医疗使用匹配,得到SG 4263例和RYGB 4520例。
- 采用校正Cox比例风险模型比较急性医疗利用,两部分logistic回归比较年度费用。
主要发现
- 术后4年内,SG组急诊就诊风险aHR 0.90(95%CI 0.85,0.96),住院风险aHR 0.80(95%CI 0.73,0.88)。
- 消化系统诊断相关事件:急诊aHR 0.68(95%CI 0.62,0.75),住院aHR 0.61(95%CI 0.53,0.72)。
- SG组高急诊费用和高总急性费用的几率更低,如第1年急性费用aOR 0.77(95%CI 0.66,0.90)。
- 第4年急性医疗费用aOR 1.10(95%CI 0.92,1.31),费用差异减弱。
临床怎么用
- 在术式选择时可考虑SG可能降低早期急诊和住院风险,尤其是消化系统相关事件。
- 需告知患者SG的费用优势可能不持久,长期急性医疗利用仍可能增加。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare acute care utilization and costs following sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB). SUMMARY BACKGROUND DATA: Comparing postbariatric emergency department (ED) and inpatient care use patterns could assist with procedure choice and provide insights about complication risk. METHODS: We used a national insurance claims database to identify adults undergoing SG and RYGB between 2008 and 2016. Patients were matched on age, sex, calendar-time, diabetes, and baseline acute care use. We used adjusted Cox proportional hazards to compare acute care utilization and 2-part logistic regression models to compare annual associated costs (odds of any cost, and odds of high costs, defined as ≥80th percentile), between SG and RYGB, overall and within several clinical categories. RESULTS: The matched cohort included 4263 SG and 4520 RYGB patients. Up to 4 years after surgery, SG patients had slightly lower risk of ED visits [adjusted hazard ratio (aHR): 0.90; 95% confidence interval (CI): 0.85,0.96] and inpatient stays (aHR: 0.80; 95% CI: 0.73,0.88), especially for events associated with digestive-system diagnoses (ED aHR: 0.68; 95% CI: 0.62,0.75; inpatient aHR: 0.61; 95% CI: 0.53,0.72). SG patients also had lower odds of high ED and high total acute costs (eg, year-1 acute costs adjusted odds ratio (aOR) 0.77; 95% CI: 0.66,0.90) in early follow-up. However, observed cost differences decreased by years 3 and 4 (eg, year-4 acute care costs aOR 1.10; 95% CI: 0.92,1.31). CONCLUSIONS: SG may have fewer complications requiring emergency care and hospitalization, especially as related to digestive system disease. However, any acute care cost advantages of SG may wane over time.
引用
- Callaway Kim K, Argetsinger S, Wharam JF, et al. Acute Care Utilization and Costs Up to 4 Years After Index Sleeve Gastrectomy or Roux-en-Y Gastric Bypass: A National Claims-based Study. Ann Surg. 2021. PMID: 34102668. doi:10.1097/SLA.0000000000004972
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。